Leidos Holdings stock (US5253271028): Raised 2026 guidance after Q1 revenue beat

Leidos Holdings boosted its full-year revenue outlook following strong Q1 results, though shares fell 8% post-earnings. Insider activity shows net selling over 24 months amid monthly stock decline.

Leidos Holdings reported robust Q1 2026 results, raising full-year revenue guidance after beating revenue expectations, according to TIKR.com as of May 2026. Despite the positive update, the stock dropped 8% following the release. Over the past month through May 2026, Leidos Holdings shares declined 12.81%, trading at $130.11, per StockTitan as of May 2026.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Leidos Holdings
• Sector/industry: Technology / Defense & Government Services
• Headquarters/country: United States
• Core markets: US government, defense, health
• Key revenue drivers: IT services, engineering, cybersecurity
• Home exchange/listing venue: NYSE (LDOS)
• Trading currency: USD

Leidos Holdings: core business model

Leidos Holdings provides scientific, engineering, systems integration and IT solutions, primarily to US government customers in defense, intelligence, civil and health markets. The company supports national security and essential civilian missions through four segments: Defense Solutions, Civil, Health and Corporate. With roots tracing back to 1969, Leidos focuses on mission-critical technologies like cybersecurity, data analytics and AI.

Revenue stems largely from long-term US government contracts, including fixed-price, cost-plus and time-and-materials arrangements. In recent years, Leidos has expanded via acquisitions, such as the 2024 merger with Gibbs & Cox to bolster maritime capabilities. This positions the firm as a key player in the $100+ billion US defense IT services market.

Main revenue and product drivers for Leidos Holdings

Defense Solutions, the largest segment, generates over 50% of revenue from DoD and intelligence community contracts, including missile defense and space systems. Civil operations serve civilian agencies like DHS and FAA with IT modernization. Health focuses on biomedical research and public health IT for HHS and VA.

Key drivers include classified programs, cloud migration services and next-gen cybersecurity tools. Leidos benefits from sovereign-backed contracts, offering stability amid geopolitical tensions. Q1 2026 strength likely reflected demand for these services, prompting the raised guidance.

Industry trends and competitive position

The defense IT sector grows at 5-7% annually, driven by modernization budgets and cyber threats, per sector reports. Leidos competes with Lockheed Martin, Northrop Grumman and Booz Allen Hamilton, holding a strong position in services with $16 billion+ market cap as of May 2026. Its services focus trades at a discount to tech-heavy peers, per Livewire Markets analysis as of May 2026.

Why Leidos Holdings matters for US investors

Listed on NYSE, Leidos offers US investors exposure to stable defense spending, which comprises 3%+ of GDP. With heavy reliance on federal budgets, the stock aligns with US fiscal policy and geopolitical risks, providing a hedge against economic volatility.

Conclusion

Leidos Holdings demonstrated operational strength in Q1 2026 with raised guidance, despite a post-earnings share dip and monthly decline to $130.11. Insider net selling over 24 months reflects mixed signals, while core defense contracts provide resilience. Investors track upcoming catalysts like federal budgets amid sector tailwinds.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.